SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001683168-24-004572
Filing Date
2024-07-01
Accepted
2024-07-01 16:05:15
Documents
14
Period of Report
2024-06-28
Items
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 FORM 8-K sunshine_8k.htm   iXBRL 8-K 26120
  Complete submission text file 0001683168-24-004572.txt   241914

Data Files

Seq Description Document Type Size
2 XBRL SCHEMA FILE sbfm-20240628.xsd EX-101.SCH 3553
3 XBRL DEFINITION FILE sbfm-20240628_def.xml EX-101.DEF 26585
4 XBRL LABEL FILE sbfm-20240628_lab.xml EX-101.LAB 36550
5 XBRL PRESENTATION FILE sbfm-20240628_pre.xml EX-101.PRE 25209
16 EXTRACTED XBRL INSTANCE DOCUMENT sunshine_8k_htm.xml XML 5523
Mailing Address 333 LAS OLAS WAY CU4 SUITE 433 FORT LAUDERDALE FL 33301
Business Address 333 LAS OLAS WAY CU4 SUITE 433 FORT LAUDERDALE FL 33301 954-515-0810
Sunshine Biopharma, Inc (Filer) CIK: 0001402328 (see all company filings)

IRS No.: 205566275 | State of Incorp.: CO | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41282 | Film No.: 241090510
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)